Published in J Pathol on January 01, 1998
Biological role of connexin intercellular channels and hemichannels. Arch Biochem Biophys (2012) 1.45
The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res (2001) 1.39
Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res (2005) 1.27
Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol (2007) 1.15
A gene expression signature associated with survival in metastatic melanoma. J Transl Med (2006) 1.13
Reduced expression of multiple gap junction proteins is a feature of cervical dysplasia. Mol Cancer (2005) 0.85
Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J Membr Biol (2007) 0.84
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer (2015) 0.83
Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS One (2014) 0.83
Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer. Int J Mol Sci (2013) 0.80
Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved. J Membr Biol (2007) 0.79
Role of connexins in infantile hemangiomas. Front Pharmacol (2013) 0.78
Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication. PLoS One (2013) 0.77
Connexin's Connection in Breast Cancer Growth and Progression. Int J Cell Biol (2016) 0.77
Expression of connexin 43 in normal canine testes and canine testicular tumors. Histochem Cell Biol (2008) 0.76
Connexin and pannexin channels in cancer. BMC Cell Biol (2016) 0.76
Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus. Reprod Toxicol (2014) 0.75
Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. Oncotarget (2015) 0.75
HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells. Viruses (2015) 0.75
Antiproliferative Action of Conjugated Linoleic Acid on Human MCF-7 Breast Cancer Cells Mediated by Enhancement of Gap Junctional Intercellular Communication through Inactivation of NF- κ B. Evid Based Complement Alternat Med (2013) 0.75
Connexin 43 in the development and progression of breast cancer: What's the connection? (Review). Int J Oncol (2017) 0.75
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet (2003) 6.15
Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer. BMJ (1994) 4.39
Screening for breast cancer. Br Med J (1976) 4.23
Psychological support for patients undergoing breast cancer surgery: a randomised study. BMJ (1996) 4.11
Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Community Health (1980) 2.95
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) (1981) 2.14
Gynaecological monitoring during tamoxifen therapy. Lancet (1994) 2.10
Granulomatous lobular mastitis. J Clin Pathol (1987) 1.92
Possible precursor of diaphragm disease in the small intestine. Lancet (1993) 1.92
Evaluating HER2 amplification and overexpression in breast cancer. J Pathol (2001) 1.89
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer (2006) 1.73
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
Therapeutic implications of the sentinel lymph node in breast cancer. Lancet (1999) 1.45
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. J Pathol (1999) 1.41
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol (1998) 1.41
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndrome. Clin Oncol (R Coll Radiol) (1995) 1.40
Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer (1999) 1.40
In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer. Thromb Haemost (1989) 1.39
The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer (1991) 1.35
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene (1997) 1.33
The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer (2012) 1.31
Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery (1995) 1.31
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma. Breast Cancer Res Treat (2003) 1.30
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Breast-conserving surgery and tumour bed positivity in patients with breast cancer. Br J Surg (1994) 1.23
Oral contraceptive use influences resting breast proliferation. Hum Pathol (1989) 1.20
Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20. Eur J Cancer (1993) 1.20
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer (2010) 1.18
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int J Cancer (1995) 1.16
Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis (1991) 1.15
P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer (1990) 1.15
Limb ischaemia after intra-arterial injection of Temazepam gel: histology of nine cases. J Clin Pathol (1994) 1.14
Early postoperative contrast radiology in the assessment of colorectal anastomotic integrity. Int J Colorectal Dis (1992) 1.13
Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer. Br J Surg (2002) 1.10
Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology (1999) 1.08
Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol (1992) 1.07
Sentinel node localization in patients with breast cancer. Br J Surg (1998) 1.06
Drill biopsy in the diagnosis of breast cancer. Clin Oncol (1975) 1.05
Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst (1995) 1.05
Breast reconstruction in the United Kingdom and Ireland. Br J Surg (2002) 1.05
Colostomy: the consequences of surgery. Clin Oncol (1976) 1.05
Warfarin inhibition of metastasis: the role of anticoagulation. Br J Surg (1987) 1.04
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun (1987) 1.02
Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy. Eur J Surg Oncol (2004) 1.02
Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer (1992) 1.01
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer. Br J Cancer (2013) 1.00
A classical osteogenic sarcoma of the breast: histology, immunohistochemistry and ultrastructure. Histopathology (1986) 1.00
Possible test for selection of adjuvant systemic therapy in early cancer of the breast. Br J Surg (1980) 0.99
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma. J Clin Pathol (2005) 0.99
Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer (1998) 0.98
A role for BRCA1 in sporadic breast cancer. Br J Cancer (2003) 0.98
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer (1988) 0.97
Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer (2004) 0.97
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer (1990) 0.96
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer (1990) 0.96
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? Br J Cancer (1998) 0.95
The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer (2012) 0.94
Recurrence of colorectal cancer after sutured and stapled large bowel anastomoses. Br J Surg (1991) 0.94
Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res (2001) 0.94
Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg Oncol (1996) 0.94
Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study. BMJ (2000) 0.93
The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer (1991) 0.93
Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg (2012) 0.93
The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer. Colorectal Dis (2012) 0.92
Three dimensional anatomy of complete duct systems in human breast: pathological and developmental implications. J Clin Pathol (1996) 0.91
Role of non-medical staff in screening for breast cancer. Br Med J (1980) 0.90
Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth. Br J Cancer (1989) 0.90
Pre-operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates. Br J Surg (1985) 0.90
Anastomotic suture materials and implantation metastasis: an experimental study. Br J Surg (1989) 0.90
Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies. J Pathol (1989) 0.90
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Recent Results Cancer Res (1984) 0.89
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. Nucl Med Commun (1987) 0.88
Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q. J Clin Pathol (2006) 0.88
Morphological and cell kinetic effects of dietary manipulation during colorectal carcinogenesis. Gut (1987) 0.88
Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy. Cancer Chemother Pharmacol (1990) 0.87
Sweet's syndrome: histological and immunohistochemical study of 15 cases. J Clin Pathol (1987) 0.87
Is small cell lung cancer the perfect target for anti-telomerase treatment? Carcinogenesis (1999) 0.87
Still waiting for predictive biomarkers in Barrett's oesophagus. J Clin Pathol (2011) 0.87
Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients. Cancer Lett (1992) 0.87
Assessment of surgical excision during breast conservation surgery by intraoperative two-dimensional specimen radiology. Br J Surg (1990) 0.86
Hospital work load produced by breast-cancer screening programme run by trained non-medical staff. Br Med J (1980) 0.86
Cytopathology in the post mortem room. J Clin Pathol (1994) 0.86
Cell kinetics in vivo of human breast cancer. Br J Surg (1996) 0.86
T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients. Immunol Lett (1992) 0.86
Experimental colorectal cancer: the relationship of diet and faecal bile acid concentration to tumour induction. Br J Surg (1986) 0.85
Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol (1998) 0.85
Long-term prognostic significance of thymidine labelling index in primary breast cancer. Eur J Cancer (1992) 0.85
Malignant melanoma of penis. J Urol (1988) 0.85
A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. Br J Cancer (2002) 0.85
Gastric emptying of a solid meal after long and short pyloroplasties. Br J Surg (1973) 0.85
Margin assessment by cavity shaving after breast-conserving surgery: analysis and follow-up of 543 patients. Eur J Surg Oncol (1999) 0.84